0001209191-20-055390.txt : 20201020
0001209191-20-055390.hdr.sgml : 20201020
20201020171643
ACCESSION NUMBER: 0001209191-20-055390
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20201013
FILED AS OF DATE: 20201020
DATE AS OF CHANGE: 20201020
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Szekeres David Leslie
CENTRAL INDEX KEY: 0001602459
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33221
FILM NUMBER: 201248898
MAIL ADDRESS:
STREET 1: C/O REGULUS THERAPEUTICS INC.
STREET 2: 3545 JOHN HOPKINS COURT, SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HERON THERAPEUTICS, INC. /DE/
CENTRAL INDEX KEY: 0000818033
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 942875566
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4242 CAMPUS POINT COURT, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8582514400
MAIL ADDRESS:
STREET 1: 4242 CAMPUS POINT COURT, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: AP PHARMA INC /DE/
DATE OF NAME CHANGE: 20010511
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED POLYMER SYSTEMS INC /DE/
DATE OF NAME CHANGE: 19920703
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2020-10-13
0
0000818033
HERON THERAPEUTICS, INC. /DE/
HRTX
0001602459
Szekeres David Leslie
4242 CAMPUS POINT COURT
SUITE 200
SAN DIEGO
CA
92121
0
1
0
0
EVP, Chief Operating Officer
Common Stock
3571
D
Employee Stock Option (Right to Buy)
16.20
2026-03-17
Common Stock
170000
D
Employee Stock Option (Right to Buy)
16.83
2026-10-07
Common Stock
50000
D
Employee Stock Option (Right to Buy)
13.00
2026-12-21
Common Stock
79167
D
Employee Stock Option (Right to Buy)
17.00
2027-12-18
Common Stock
90000
D
Employee Stock Option (Right to Buy)
24.97
2028-12-15
Common Stock
92000
D
Employee Stock Option (Right to Buy)
25.02
2029-12-19
Common Stock
115000
D
Employee Stock Option (Right to Buy)
15.72
2030-10-13
Common Stock
156000
D
Restricted Stock Units
0.00
Common Stock
20000
D
The stock option is fully vested and exercisable.
The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant.
The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant.
/s/ Lisa Peraza Attorney-in-fact for David Szekeres
2020-10-20
EX-24.3_942031
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
I hereby constitute and appoint Lisa Peraza as my true and lawful
attorney-in-fact to:
(1) execute for and on behalf of the undersigned, in the undersigned's capacity
as an officer and/or director of Heron Therapeutics, Inc. (the "Company"), Forms
3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of
1934, as amended (the "Act"), and the rules thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such Form 3, 4 or 5
and timely file such form with the United States Securities and Exchange
Commission and any stock exchange or similar authority; and
(3) take any other action in connection with the foregoing which, in the opinion
of such attorney-in-fact, is intended to benefit, is in the best interest of, or
legally required by, the undersigned, it being understood that the documents
executed by such attorney-in-fact on behalf of the undersigned pursuant to this
Power of Attorney shall be in such form and shall contain such terms and
conditions as such attorney-in-fact may approve.
The undersigned hereby grants to each attorney-in-fact full power and authority
to do and perform any act requisite, necessary or proper to be done in the
exercise of any of the rights and powers herein granted, as fully to all intents
and purposes as the undersigned might or could do if personally present, with
full power of substitution or revocation, hereby ratifying and confirming all
the acts such attorney-in-fact shall lawfully do or cause to be done by virtue
of this power of attorney and the rights and powers herein granted. The
undersigned acknowledges that each foregoing attorney-in-fact, in serving in
such capacity at the request of the undersigned, is not assuming any of the
undersigned's responsibilities to comply with Section 16 of the Act.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorney-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of the date set forth below.
By: /s/ David Szekeres
Print Name: David Szekeres
Date: 10/14/2020